ContextVision ABOSL:CONTX -0.60%79 5-Year Yield-on-Cost % is 0.00 as of Jul. 13, 2026. GuruFocus rates OSL:CONTX with a GF Score™ of 79/100 and a GF Value™ of kr5.12 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 281 Healthcare Providers & Services companies, ContextVision AB ranks worse than 355871.53% on this metric.
ContextVision AB's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for ContextVision AB's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, ContextVision AB's highest Yield on Cost was 5.33. The lowest was 1.73. And the median was 2.80.
OSL:CONTX's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.92 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
ContextVision AB (OSL:CONTX) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
ContextVision AB 5-Year Yield-on-Cost % Related Terms
OSL:CONTX vs VEEV, BTSG, TEM: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, ContextVision AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ContextVision AB 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where ContextVision AB's 5-Year Yield-on-Cost % falls into.
ContextVision AB 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
ContextVision AB (OSL:CONTX) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on ContextVision AB and its competitors. Over the past decade, ContextVision AB's 5-Year Yield-on-Cost % has ranged from 1.73 to 5.33. According to the industry distribution chart, ContextVision AB ranks #999999 out of 281 companies in the Healthcare Providers & Services industry.
Is ContextVision AB's 5-Year Yield-on-Cost % too high?
ContextVision AB's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.73 to a high of 5.33. Based on the distribution chart, ContextVision AB ranks #999999 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, ContextVision AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ContextVision AB's 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ContextVision AB ranks #999999 out of 281 companies for 5-Year Yield-on-Cost %. This places ContextVision AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. Historically, ContextVision AB's own 5-Year Yield-on-Cost % has ranged from 1.73 to 5.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on ContextVision AB and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ContextVision AB's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContextVision AB stock overvalued right now?
Based on GuruFocus' analysis, ContextVision AB (OSL:CONTX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr5.12, compared to a current price of kr3.34 — trading 34.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. ContextVision AB's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For ContextVision AB (OSL:CONTX), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ContextVision AB (OSL:CONTX) Overvalued in 2026?
Based on GuruFocus' analysis, ContextVision AB stock appears to be undervalued.
The current stock price of kr3.34 is trading 34.8% below its estimated GF Value™ of kr5.12.
GuruFocus considers ContextVision AB to be Significantly Undervalued.
Key valuation signals for OSL:CONTX:
5-Year Yield-on-Cost %: 0.00
GF Value™: kr5.12 vs. price of kr3.34 (34.8% below fair value)
No single metric tells the full story. See the OSL:CONTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
79GF Score
Get the complete analysis for OSL:CONTX
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CONTX has been successfully added to your 
